Technology sentiment, Palantir earnings, and discount rates Technology sentiment, Palantir earnings, and discount rates Technology sentiment, Palantir earnings, and discount rates

Technology sentiment, Palantir earnings, and discount rates

Equities 10 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  Technology sentiment is as dark as when the dot-com bubble burst with many companies seeing their stocks decline by 50-90%. We take a look at some of these names, but which are also profitable, because it is during these periods when some of these companies can be bought at good risk-reward levels. We also take a look at Palantir's Q1 earnings release which disappointed on its Q2 revenue outlook sending the shares down in pre-market trading. Finally, we show how equity valuations are impacted from higher interest rates without any change to the underlying business.

Sentiment in technology stocks is plummeting

The tweet last Wednesday by David Sacks that “Investor sentiment in Silicon Valley is the most negative since the dot-com crash” tells you everything you need to know. The decline in high growth non-profitable companies, which we call bubble stocks, has been -69% since the peak in February 2021. Our bubble stocks basket has basically come back to the levels from before the pandemic. For some stocks it has been brutal such as Zoom, Teladoc, PayPal, and Pinterest, and we have seen that crypto related instruments are a high beta expression of liquidity preference and technology sentiment. The higher discount rate on cash flows are not only compressing equity valuations but also changing investors’ time preference demanding break-even faster than before.

Not all technology stocks are created equally with some of these fallen technology stocks actually being profitable. The list below is a list of US-listed stocks which are down more than 50% since 14 February 2021 and have a positive free cash flow yield; the list below is not meant as investment recommendations but highlighting companies with positive free cash flows yields that have been beaten down heavily. While many investors are suffering it is often during these periods of stress where investors can find very attractive long-term opportunities.

  • Teladoc Health (Return: -88.6%, FCF yld: 4.95%)
  • Zoom Video (Return: -77.8%, FCF yld: 5.2%)
  • Pinterest (Return: -73%, FCF yld: 4.6%)
  • PayPal (Return: -72.6%, FCF yld: 5.2%)
  • DocuSign (Return: -71.7%, FCF yld: 3.0%)
  • Bumble (Return: -71%, FCF yld: 3.3%)
  • Alibaba (Return: -66.4%, FCF yld: 8%)
  • Etsy (Return: -63.1%, FCF yld: 4.8%)
  • Baidu (Return: -62.7%, FCF yld: 3.4%)
  • Rackspace (Return: -60.6%, FCF yld: 12.9%)


The list below shows that current constituents in our bubble basket.

NameMkt Cap (USD mn.)12M Fwd EPS12M Fwd EV/SalesDiff to PT (%)5yr return (%)YTD return (%)
Lucid Group Inc30,271-1.0913.297.0NA-52.3
Cellnex Telecom SA29,281-0.1512.457.4228.2-20.3
Rivian Automotive Inc25,929-6.042.7155.0NA-72.2
NU Holdings Ltd/Cayman Islands24,2480.016.096.6NA-44.2
Seagen Inc22,722-2.5810.330.297.4-20.2
MongoDB Inc20,250-0.1815.355.4NA-43.4
SenseTime Group Inc20,062-0.0716.139.7NA-14.5
Unity Software Inc16,971-0.0910.3130.6NA-59.9
BeiGene Ltd16,673-10.486.0116.9288.1-45.6
Argenx SE16,369-17.6051.715.21,650.9-8.4
Alnylam Pharmaceuticals Inc16,280-4.4911.651.8141.9-20.5
Okta Inc16,054-1.068.0112.0336.9-54.3
Brookfield Renewable Corp13,0050.209.98.3NA0.7
Shanghai Junshi Biosciences Co Ltd12,664-1.0926.634.1NA1.3 Holdings Inc12,616-0.3713.998.9NA-51.4
Grab Holdings Ltd11,532-0.373.385.6NA-57.8
Plug Power Inc11,221-0.427.4112.6804.9-31.2
Qualtrics International Inc10,4640.036.4101.4NA-49.2
Wolfspeed Inc10,000-0.029.745.7254.9-27.6
Robinhood Markets Inc8,823-
Novocure Ltd7,653-0.5412.940.6494.9-2.5
SentinelOne Inc7,253-0.7113.089.9NA-48.3
Affirm Holdings Inc7,097-1.823.7143.7NA-75.2
Avalara Inc6,8900.026.857.6NA-39.3
Procore Technologies Inc6,777-0.708.661.0NA-37.5
Kingdee International Software Group Co Ltd6,700-0.057.460.7365.1-36.9
Confluent Inc6,605-0.699.1101.2NA-68.9
Guidewire Software Inc6,450-
Biohaven Pharmaceutical Holding Co Ltd6,365-6.396.274.8312.7-34.5
Gitlab Inc6,254-0.9112.473.3NA-51.3
Elastic NV6,092-0.255.490.8NA-47.0
10X Genomics Inc5,804-0.797.885.6NA-65.6
Smartsheet Inc5,625-0.596.452.8NA-43.6
Samsara Inc5,625-0.247.8148.9NA-60.7 Ltd5,550-2.858.787.8NA-60.0
Ginkgo Bioworks Holdings Inc4,810-0.209.3243.2NA-67.4
Asana Inc4,752-1.248.1112.7NA-66.5
Ascendis Pharma A/S4,730-7.7141.5114.1200.0-38.2
Guardant Health Inc4,008-4.567.3211.2NA-60.7
Intellia Therapeutics Inc3,608-5.7956.5187.3234.5-59.8
Aggregate / median464,0838.786.7271.5-44.9

Palantir down 11% on outlook miss

Palantir is another very popular technology and growth stock that was IPO’ed in late 2020 which has seen it share price collapse to below $10 last Friday from as high as $45 in January 2021. The big data analytics company with prominent US government contracts reported Q1 results that were in line with estimates growing revenue 31% y/y in Q1 and still delivering an operating loss. However, it was the Q2 revenue guidance of $470mn vs est. $487mn that caused investors to sell shares in pre-market taking the shares down by 11%. The operating margin is improving but judging from the market reaction investors want to see it improving faster per our discussion of equity valuation dynamics related to discount rates (see section below).

Source: Saxo Group

Discount dynamics on equity valuation

The venture capital investor Bill Gurley said in late April that entire generation of entrepreneurs and technology investors will learn equity valuation the hard way and that the “unlearning” process could be painful, surprising and unsettling to many, and that he anticipates denial. Equity valuations like interest rates have had one direction only culminating in late 2020 and early 2021. But with rising interest rates and inflation the entire equity valuation game is changing and investors will demand business models that can break-even faster than before.

To get a sense of what the US interest rate move is doing to equity valuations let us look at a very simplified example. We have a company (no debt and no non-operating assets), growing revenue at 20% p.a. for 10 years with a NOPAT (net operating profit after tax) margin of 20% with a reinvestment rate of 10% per incremental revenue. The equity risk premium is 5% and in the first period the risk-free rate is 0.5% (equivalent to the US 10-year yield in 2020). The present value of those future free cash flows including the terminal value (the present value of continuing value) is $1,359 equating to a 1-year forward free cash flow yield of 1.6%. What happens to this company if everything is unchanged except for the risk-free rate moving from 0.5% to 3.2%? The value of those future cash flows drop to $831 and the equity valuation (1-year free cash flow yield) goes to 2.6%. The drop in equity value is equivalent to 39% for a 2.7%-points move in the risk-free rate which equates to an equity duration of 14x.

Anyone that knows equity valuation dynamics understand the importance of continuing value (terminal value). The dynamic that is amplifying the moves in equity valuation when you have a large correction in technology stocks is that technology investors are beginning to cut their expectations for the long-term outlook for margins and reinvestment rate etc. so the upward move in interest rates are amplified through several factors in the modelling of the present value of future cash flows.

Source: Saxo Group
Source: Saxo Group

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.